Citizens Maintains Market Outperform on Ironwood Pharmaceuticals, Raises Price Target to $10
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst Jason N. Butler maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Market Outperform and raises the price target from $8 to $10.
Citizens analyst Jason N. Butler maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Market Outperform and raises the price target from $8 to $10.